AcelRx Pharmaceuticals Inc
NASDAQ:ACRX
AcelRx Pharmaceuticals Inc
NASDAQ:ACRX
Price:
1.1277 USD
2.52%
Updated:
May 3, 2024
AcelRx Pharmaceuticals Inc
Net Income (Common)
|
AcelRx Pharmaceuticals Inc
Net Income (Common) Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
AcelRx Pharmaceuticals Inc
NASDAQ:ACRX
|
Net Income (Common)
-$26.5m
|
CAGR 3-Years
17%
|
CAGR 5-Years
10%
|
CAGR 10-Years
6%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Net Income (Common)
$40.6B
|
CAGR 3-Years
39%
|
CAGR 5-Years
23%
|
CAGR 10-Years
10%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Net Income (Common)
-$6.1B
|
CAGR 3-Years
0%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Pfizer Inc
NYSE:PFE
|
Net Income (Common)
$2.1B
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
-21%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Net Income (Common)
$2.3B
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-7%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Net Income (Common)
$5.2B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
10%
|
CAGR 10-Years
1%
|
See Also
What is AcelRx Pharmaceuticals Inc's Net Income (Common)?
Net Income (Common)
-26.5m
USD
-26.5m
USD
Based on the financial report for Sep 30, 2023, AcelRx Pharmaceuticals Inc's Net Income (Common) amounts to -26.5m USD.
What is AcelRx Pharmaceuticals Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
6%
6%
The average annual Net Income (Common) growth rates for AcelRx Pharmaceuticals Inc have been 17% over the past three years , 10% over the past five years , and 6% over the past ten years .
You don't have any saved screeners yet
